EDSA (Edesa Biotech) Cyclically Adjusted Book per Share: $69.11 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EDSA Edesa Biotech Inc EDSA
26 GF Score
Price $5.35
! 2 Warning Signs
View Full Analysis

What is Edesa Biotech Cyclically Adjusted Book per Share?

Edesa Biotech EDSA -3.08% 26 Cyclically Adjusted Book per Share is $69.11 as of Jun. 2026. GuruFocus rates EDSA with a GF Score™ of 26/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Edesa Biotech's adjusted book value per share for the three months ended in Jun. 2026 was $0.041. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $69.11 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Edesa Biotech's average Cyclically Adjusted Book Growth Rate was -34.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -15.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -11.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Edesa Biotech was -4.40% per year. The lowest was -15.00% per year. And the median was -11.90% per year.

As of today (2026-08-17), Edesa Biotech's current stock price is $5.35. Edesa Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $69.11. Edesa Biotech's Cyclically Adjusted PB Ratio of today is 0.08.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Edesa Biotech was 0.34. The lowest was 0.01. And the median was 0.07.


Edesa Biotech  (NAS:EDSA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Edesa Biotech's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=5.35/69.11
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Edesa Biotech was 0.34. The lowest was 0.01. And the median was 0.07.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Edesa Biotech Cyclically Adjusted Book per Share Related Terms


Edesa Biotech Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Edesa Biotech's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edesa Biotech Cyclically Adjusted Book per Share Chart

Edesa Biotech Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 165.06 157.29 177.14 136.24 96.46

Edesa Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.75 96.46 85.71 77.01 69.11

EDSA vs TCRX, DWTX, AURX: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Edesa Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edesa Biotech Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Edesa Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Edesa Biotech's Cyclically Adjusted PB Ratio falls into.


EDSA
26GF Score
Edesa Biotech Inc EDSA
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edesa Biotech Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Edesa Biotech's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.041/133.5265*133.5265
=0.041

Current CPI (Jun. 2026) = 133.5265.

Edesa Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201609 362.176 101.765 475.215
201612 319.559 101.449 420.604
201703 287.941 102.634 374.611
201706 238.806 103.029 309.496
201709 205.528 103.345 265.552
201712 167.194 103.345 216.023
201803 131.667 105.004 167.432
201806 97.535 105.557 123.379
201809 88.874 105.636 112.339
201812 78.016 105.399 98.836
201903 65.118 106.979 81.277
201906 5.796 107.690 7.187
201909 4.903 107.611 6.084
201912 3.950 107.769 4.894
202003 5.475 107.927 6.774
202006 4.220 108.401 5.198
202009 4.826 108.164 5.958
202012 5.246 108.559 6.453
202103 10.187 110.298 12.332
202106 8.344 111.720 9.973
202109 6.876 112.905 8.132
202112 5.463 113.774 6.411
202203 7.707 117.646 8.747
202206 5.359 120.806 5.923
202209 3.946 120.648 4.367
202212 3.715 120.964 4.101
202303 3.140 122.702 3.417
202306 2.633 124.203 2.831
202309 2.292 125.230 2.444
202312 1.847 125.072 1.972
202403 1.345 126.258 1.422
202406 0.883 127.522 0.925
202409 0.610 127.285 0.640
202412 0.370 127.364 0.388
202503 0.905 129.181 0.935
202506 0.699 129.892 0.719
202509 0.447 130.287 0.458
202512 0.559 130.366 0.573
202603 0.205 132.262 0.207
202606 0.041 133.527 0.041

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $69.11 mean?
Edesa Biotech (EDSA) has a Cyclically Adjusted Book per Share of $69.11 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Edesa Biotech and its competitors.
Is Edesa Biotech's Cyclically Adjusted Book per Share too high?
Edesa Biotech's current Cyclically Adjusted Book per Share is $69.11. Overall, Edesa Biotech has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Edesa Biotech's Cyclically Adjusted Book per Share compare to TCRX and DWTX?
Edesa Biotech's Cyclically Adjusted Book per Share of $69.11 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Edesa Biotech and its competitors. Edesa Biotech's current Cyclically Adjusted Book per Share is $69.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edesa Biotech stock overvalued right now?
Edesa Biotech (EDSA) has a current Cyclically Adjusted Book per Share of $69.11. The current Cyclically Adjusted Book per Share is $69.11. Edesa Biotech's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Edesa Biotech (EDSA), the current Cyclically Adjusted Book per Share is $69.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Edesa Biotech Business Description

Address 100 Spy Court, Markham, ON, CAN, L3R 5H6
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
26GF Score

Get the complete analysis for EDSA

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.35
Price